Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - SHARES OUTSTANDING
Shares Outstanding REPL - Replimune Group, Inc.
66.6 M
LAST VALUE
12.92%
2 YEAR CAGR
23.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR